Altrafin AG
- SEC CIK
- 0002110313
- Latest filing
- Jul 20, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Altrafin AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 139,963
- Value
- $6.71M
- % of portfolio
- 2.6%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 139,963 | $6.71M | 2.6% | −34,450−19.8% | Reduced | Holders |
| Q1 2026 | 174,413 | $6.41M | 2.2% | −770−0.4% | Reduced | Holders |
| Q4 2025 | 175,183 | $8.91M | 2.8% | −72,922−29.4% | Reduced | Holders |
| Q3 2025 | 248,105 | $13.8M | 4.4% | +19,706+8.6% | Added | Holders |
| Q2 2025 | 228,399 | $15.8M | 5.3% | +39,816+21.1% | Added | Holders |
| Q1 2025 | 188,583 | $13.1M | 5.1% | +52,137+38.2% | Added | Holders |
| Q4 2024 | 136,446 | $11.7M | 4.1% | +37,151+37.4% | Added | Holders |
| Q3 2024 | 99,295 | $11.8M | 4.3% | +42,668+75.3% | Added | Holders |
| Q2 2024 | 56,627 | $8.08M | 3.0% | −30.0% | Reduced | Holders |
| Q1 2024 | 56,630 | $7.27M | 2.6% | +190.0% | Added | Holders |
| Q4 2023 | 56,611 | $5.86M | 2.3% | −2,161−3.7% | Reduced | Holders |
| Q3 2023 | 58,772 | $5.34M | 2.3% | +3,350+6.0% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 27,711 | $4.48M | 2.0% | −69−0.2% | Reduced | Holders |
| Q1 2023 | 27,780 | $4.42M | 2.2% | −5,909−17.5% | Reduced | Holders |
| Q4 2022 | 33,689 | $4.56M | 2.7% | +746+2.3% | Added | Holders |
| Q3 2022 | 32,943 | $3.28M | 2.0% | +734+2.3% | Added | Holders |
| Q2 2022 | 32,209 | $3.59M | 1.9% | −7,506−18.9% | Reduced | Holders |
| Q1 2022 | 39,715 | $4.41M | 1.7% | +5,438+15.9% | Added | Holders |
| Q4 2021 | 34,277 | $3.84M | 1.4% | – | No prior filing | Holders |